Operating income before deduction of amortization: revvity.com (RVTY)

Graphic logo of revvity.com (RVTY)

EBITDA for Revvity, Inc. (RVTY), as shown on the GURU.Markets chart, demonstrates stability, with the value holding at 872.98. This trend is supported by outsourcing services and component production to external partners, as well as a systemic transition to eco-friendly reagents and packaging recycling. Overall resilience is based on a broad client reach, ranging from pharma behemoths to research centers.

Profit before payment of interest, taxes and amortization: Revvity, Inc. (RVTY) for 11/23/2025 - 11/10/2026

Revvity (RVTY) - metric breakdowns and financial figures

- market value and analyst target forecast:
Market Price Revvity Corp|RVTY - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Revvity|RVTY - Enterprise Value
- balance sheet equity data:
Net Assets per Share Revvity|RVTY - Company Book Value|Market Capitalization to Book Value revvity.com|RVTY - Aggregate Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Revvity, Inc.|RVTY - Long-Term Debt to Capital|Current Liabilities to Capital Revvity Inc|RVTY - Company Total Debt|Debt to Book Capitalization Ratio Revvity|RVTY - Company Long-Term Liabilities|Company Short-Term Debt Revvity|Interim Coverage Ratio revvity.com
- company profitability and valuation multiples indicators:
RVTY - Net Income|Future Net Profit Revvity, Inc.|RVTY - Price to Earnings Ratio|Projected Price to Earnings Ratio revvity.com|RVTY - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Revvity|RVTY - Operating profit EBITDA|Net earnings per share for the last four quarters Revvity|RVTY - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months revvity.com|RVTY - Earnings growth in current year|Expected earnings per share growth for next year Revvity, Inc.
Fundamental company valuation:Revvity Corp (RVTY)
Brand item of Revvity, Inc.

Market expectations often overestimate the scale of Revvity, Inc. (RVTY), whereas real resilience is confirmed by cash flow. This indicator captures the daily cash volume from core operations, excluding non-cash charges. By analyzing the cash EBITDA trend, an investor can see the actual liquidity of the business. For Revvity, Inc. (RVTY), this metric reflects stable income from the sale of high-margin reagents following equipment installation. The rising curve confirms the effectiveness of long-term customer lock-in to the company's technologies.

Competitor analysis for Revvity, Inc.

Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|BIO - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Anbio Tech|Nordion (SHC) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization QuidelOrtho (QDEL)|OPK (opko.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA CDNA (CareDx Inc)|Maravai LifeSciences Holdings (MRVI) - Profit before interest, taxes and amortization|FLGT: Operating profit before deduction of amortization|LAB: Profit before payment of interest, taxes and amortization|CTKB (Cytek Biosciences, Inc.) - Operating profit before deduction of amortization|OSUR (orasure.com) - Profit before payment of interest, taxes and amortization|XGN (Exagen Inc) - Operating profit EBITDA|MDxHealth S.A. (MDXH) - Operating income before deduction of amortization|Operating profit before deduction of amortization LUCD (Lucid Diagnostics Inc)|Company profit before taxes, interest and amortization PRE|Insight Molecular Diagnostics Inc - Operating profit before deduction of amortization|Trinity Biotech PLC (TRIB) - Profit before interest, taxes and amortization|PRPH: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AIMD (Ainos Inc)|CODX: Operating profit EBITDA|HSCS - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Biomerica, Inc.|Operating profit before amortization CDIO (Cardio Diagnostics Holdings, Inc.)|Operating profit EBITDA ONCO|Operating profit before deduction of amortization Virax Biolabs Group Limited VRAX|Bluejay - Operating profit before deduction of amortization|Operating income before deduction of amortization Aspira Women's Health Inc (AWH)|AXDX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CNTG (Centogene)|ENZ (enzo.com) - Operating profit before deduction of amortization|FRES (Fresh2 Group) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization GENE|ME (23andMe Inc) - Company profit before taxes, interest and amortization|Operating profit before deduction of amortization PMD (Psychemedics)